Notice Information
Notice Title
Large volume human serum or human defibrinated plasma containing autoantibodies to thyroid peroxidase (anti-TPO) at a titre >1000 IU/ml
Notice Description
The agency is looking to purchase a 2500 ml volume of human serum or human defibrinated plasma containing autoantibodies to thyroid peroxidase (anti-TPO) at a titre >1000 IU/ml. Essential requirements are as follows: - The volume must comprise units from different individual donors. - Units must be certified by the supplier to be negative for viral markers including, as a minimum, viral markers for HIV, Hepatitis B and Hepatitis C - The concentration of anti-TPO must be reported by the supplier and be >1000 IU/mL as determined by an anti-TPO immunoassay. - Samples of a minimum volume, 2 ml, must be available to the customer free of charge for in-house testing to ensure material will be fit-for-purpose before continuing with any competition if required, i.e. tender/evaluations, or via direct award. - Donor units must be reserved while in-house testing takes place for a maximum time of 3 months. Desirable requirements are as follows: - Suppliers should be able to confirm if donors have refrained from taking supplements (e.g. Biotin) in the period leading up to their donation. If you can provide plasma or serum that meets these requirements, please email to Nawaz Habib (nawaz.habib@nibsc.org) to register an interest. If no submissions (by close of play 28 March 2019) of potential interest are received, it is then intended to perform a direct award without competition to the sole supplier we believe can supply this material.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-d41bc52d-1b85-4afa-871c-4d6e1cf6fafa
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/2398c039-09bf-491f-90d7-bc5c19989dff
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Market Engagement Notice
- Procurement Type
- Standard
- Procurement Category
- Not specified
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
73 - Research and development services and related consultancy services
-
- CPV Codes
33141520 - Plasma extracts
33141560 - Human organs
33141570 - Human blood
33698000 - Clinical products
33698100 - Microbiological cultures
73111000 - Research laboratory services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 11 Mar 20196 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 28 Mar 2019Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planning
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MHRA BUYER ORGANISATION
- Contact Name
- Not specified
- Contact Email
- nawaz.habib@nibsc.org
- Contact Phone
- Not specified
Buyer Location
- Locality
- POTTERS BAR
- Postcode
- EN6 3QG
- Post Town
- Enfield
- Country
- England
-
- Major Region (ITL 1)
- TLH East (England)
- Basic Region (ITL 2)
- TLH2 Bedfordshire and Hertfordshire
- Small Region (ITL 3)
- TLH27 South West Hertfordshire
- Delivery Location
- Not specified
-
- Local Authority
- Hertsmere
- Electoral Ward
- Shenley
- Westminster Constituency
- Hertsmere
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/2398c039-09bf-491f-90d7-bc5c19989dff
11th March 2019 - Early engagement notice on Contracts Finder -
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-d41bc52d-1b85-4afa-871c-4d6e1cf6fafa-2019-03-11T16:39:25Z",
"date": "2019-03-11T16:39:25Z",
"ocid": "ocds-b5fd17-d41bc52d-1b85-4afa-871c-4d6e1cf6fafa",
"language": "en",
"initiationType": "tender",
"title": "Large volume human serum or human defibrinated plasma containing autoantibodies to thyroid peroxidase (anti-TPO) at a titre >1000 IU/ml",
"planning": {
"milestones": [
{
"id": "1",
"title": "Engagement end date",
"type": "engagement",
"dueDate": "2019-03-28T23:59:59Z"
}
],
"documents": [
{
"id": "1",
"documentType": "marketEngagementNotice",
"description": "Early engagement notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/2398c039-09bf-491f-90d7-bc5c19989dff",
"datePublished": "2019-03-11T16:39:25Z",
"format": "text/html",
"language": "en"
},
{
"id": "2",
"documentType": "tenderNotice",
"description": "MHRA bravo etendering portal Weblink",
"url": "https://mhra.bravosolution.co.uk/web_mhra/login.html"
}
]
},
"tender": {
"id": "tender_163947/752326",
"title": "Large volume human serum or human defibrinated plasma containing autoantibodies to thyroid peroxidase (anti-TPO) at a titre >1000 IU/ml",
"description": "The agency is looking to purchase a 2500 ml volume of human serum or human defibrinated plasma containing autoantibodies to thyroid peroxidase (anti-TPO) at a titre >1000 IU/ml. Essential requirements are as follows: - The volume must comprise units from different individual donors. - Units must be certified by the supplier to be negative for viral markers including, as a minimum, viral markers for HIV, Hepatitis B and Hepatitis C - The concentration of anti-TPO must be reported by the supplier and be >1000 IU/mL as determined by an anti-TPO immunoassay. - Samples of a minimum volume, 2 ml, must be available to the customer free of charge for in-house testing to ensure material will be fit-for-purpose before continuing with any competition if required, i.e. tender/evaluations, or via direct award. - Donor units must be reserved while in-house testing takes place for a maximum time of 3 months. Desirable requirements are as follows: - Suppliers should be able to confirm if donors have refrained from taking supplements (e.g. Biotin) in the period leading up to their donation. If you can provide plasma or serum that meets these requirements, please email to Nawaz Habib (nawaz.habib@nibsc.org) to register an interest. If no submissions (by close of play 28 March 2019) of potential interest are received, it is then intended to perform a direct award without competition to the sole supplier we believe can supply this material.",
"status": "planning",
"classification": {
"scheme": "CPV",
"id": "33141520",
"description": "Plasma extracts"
},
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141560",
"description": "Human organs"
},
{
"scheme": "CPV",
"id": "33141570",
"description": "Human blood"
},
{
"scheme": "CPV",
"id": "33698000",
"description": "Clinical products"
},
{
"scheme": "CPV",
"id": "33698100",
"description": "Microbiological cultures"
},
{
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "East of England",
"countryName": "United Kingdom"
}
]
}
],
"suitability": {
"sme": false,
"vcse": false
}
},
"parties": [
{
"id": "GB-CFS-106977",
"name": "MHRA Buyer Organisation",
"identifier": {
"legalName": "MHRA Buyer Organisation"
},
"address": {
"streetAddress": "NIBSC, Blanche Lane, South Mimms,",
"locality": "Potters Bar",
"postalCode": "EN6 3QG",
"countryName": "England"
},
"contactPoint": {
"email": "nawaz.habib@nibsc.org"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-CFS-106977",
"name": "MHRA Buyer Organisation"
}
}